Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of protease inhibitors and other biologically active molecules. Its structure supports the construction of complex organic frameworks through peptide coupling and cyclization reactions. Commonly employed in medicinal chemistry for modifying drug candidates to enhance stability, selectivity, and binding affinity. Also utilized in solid-phase and solution-phase peptide synthesis due to the presence of the Cbz-protecting group, which allows for selective deprotection under mild conditions.